Unilever risks becoming a takeover target as it pursues GSK's consumer healthcare arm

Unilever's £50bn offer for the consumer healthcare arm of Glaxosmithkline (GSK) has been rejected - but this feels like the start of what could turn out to be a protracted takeover battle.